Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Case-By-Case Guide As Justices Eye Landmark Pharma Law No Photo Available

Jeff Overley

Drugmakers and prominent allies are inundating the U.S. Supreme Court with calls to scrutinize Medicare's new power to slash payments ... (more story)

Compound GLP-1s, Anesthesia Prices And More In Court No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at appellate arguments from compounding pharmacies alleging they were wrongly barred from making the... (more story)

FTC's Probes Of Trans Care Orgs Raise Jurisdiction Concerns No Photo Available

Mark Payne

The Federal Trade Commission's demands for information from transgender care organizations may be exceeding the agency's authority to ... (more story)